MedTrace Logo

Biomarkers for Feeding Intolerance in Infants With Complex Congenital Heart Defects Undergoing Single Ventricle Staged Palliation

NCT02995577 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-12-16

No results posted yet for this study

Summary

The purpose of this study is to investigates serum and stool biomarkers as predictors for post-operative feeding intolerance in infant patients with complex congenital heart defects who undergo single ventricle staged palliation surgery.

Conditions

  • Single Ventricle Physiology

Interventions

OTHER

Feeding tolerant

OTHER

Feeding intolerant

OTHER

Necrotizing enterocolitis

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Supriya Nair, MD · The University of Texas Health Science Center, Houston

Eligibility

Min Age
1 Day
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02995577 on ClinicalTrials.gov